Adverse Events Common With Triple Therapy in HCV CirrhosisAdverse Events Common With Triple Therapy in HCV Cirrhosis

In cirrhotic patients, triple-therapy against hepatitis C virus (HCV) produces a high virological response rate, but at the cost of a high rate of serious adverse events, French researchers say. Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news